Clinical Trials Logo

Recurrent Small Intestine Cancer clinical trials

View clinical trials related to Recurrent Small Intestine Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00433550 Active, not recruiting - Clinical trials for Small Intestine Adenocarcinoma

Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer

Start date: May 2007
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well giving irinotecan hydrochloride together with oxaliplatin and capecitabine works as first-line therapy in treating patients with metastatic or unresectable locally advanced small bowel cancer. Drugs used in chemotherapy, such as irinotecan hydrochloride, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.